Poor insight in schizophrenia is prevalent across cultures and phases of illness. In this
review, we examine the recent research on the relationship of insight with behavior, mood …

Objective: Antipsychotic medication non-adherence has detrimental effects on patients'
clinical outcome. It is unclear which risk factors affect adherence most and which …

Adherence to prescribed medication regimes improves outcomes for patients with severe
mental illness such as schizophrenia or bipolar disorders. The aim of this systematic review …

Objectives To systematically review published randomized controlled trials (RCTs)
assessing the efficacy of MI to support medication adherence in adults with chronic …

Nonadherence to medications is very common in people with schizophrenia. Numerous
methods have been implemented to improve medication adherence. The study aimed to …

Objective To describe the approval of olanzapine/samidorphan, compare the clinical trial
data, and summarize key findings, with a focus on impact to clinical practice. Data Sources A …

Background Current practice guidelines for schizophrenia care recommend that
antipsychotic medication is essential for patients' long-term maintenance treatment but their …

Objective: Over the past decade, cognitive behavioral therapy has been applied to an
increasingly wider range of disorders and problems in Chinese societies. However, no meta …

Background Poor adherence to medication in schizophrenia spectrum disorders leads to
inadequate symptom control. Adherence therapy (AT) is an intervention that seeks to reduce …

Essential criteria for the methodological quality and validity of randomized controlled trials
are the drop-out rates from both the experimental intervention and the study as a whole. This …